Using AI to discover new treatments for Alzheimer's disease
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
['FUNDING_U01'] · CLEVELAND CLINIC LERNER COM-CWRU · NIH-10899646
This study is looking at the genetic factors behind Alzheimer's disease using advanced technology to help find new ways to treat it, so that patients can have better options for managing their condition.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CLEVELAND CLINIC LERNER COM-CWRU (nih funded) |
| Locations | 1 site (CLEVELAND, UNITED STATES) |
| Trial ID | NIH-10899646 on ClinicalTrials.gov |
What this research studies
This research investigates the complex genetic factors contributing to Alzheimer's disease by utilizing advanced artificial intelligence and multi-omics data. It aims to integrate various biological data types, such as genetics and protein interactions, to better understand the disease's mechanisms. By identifying new risk genes and potential drug targets, the research seeks to pave the way for innovative therapeutic interventions that could slow down or modify the disease's progression. Patients may benefit from the insights gained through this comprehensive approach to Alzheimer's treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new, effective treatments for Alzheimer's disease that address its underlying causes.
How similar studies have performed: Other research has shown promise in using AI and multi-omics approaches for understanding complex diseases, suggesting potential for success in this novel application.
Where this research is happening
CLEVELAND, UNITED STATES
- CLEVELAND CLINIC LERNER COM-CWRU — CLEVELAND, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHENG, FEIXIONG — CLEVELAND CLINIC LERNER COM-CWRU
- Study coordinator: CHENG, FEIXIONG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease, Alzheimer's disease and related dementia, Alzheimer's disease and related disorders